Cargando...
Antimicrobial peptide exposure selects for Staphylococcus aureus resistance to human defence peptides
BACKGROUND: The clinical development of antimicrobial peptides (AMPs) is currently under evaluation to combat the rapid increase in MDR bacterial pathogens. However, many AMPs closely resemble components of the human innate immune system and the ramifications of prolonged bacterial exposure to AMPs...
Gardado en:
| Publicado en: | J Antimicrob Chemother |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2017
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5161045/ https://ncbi.nlm.nih.gov/pubmed/27650186 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jac/dkw381 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|